Celerion Pledges Commitment to the SBTi Net-Zero Standard
04 Dec 2024 //
BUSINESSWIRE
Celerion`s US Pharmacies Expand Services For Phase 1 Drug Compliance
17 Jul 2024 //
BUSINESSWIRE
Celerion: Wins CRO Leadership Award For 9th Straight Year
05 Jun 2024 //
BUSINESSWIRE
Jo Goodman Joins Celerion as Vice President of Bioanalytical Services
07 May 2024 //
BUSINESSWIRE
AstraZeneca alum Jo Goodman joins executive team at Celerion
07 May 2024 //
FIERCE BIOTECH
Celerion Achieves Milestone With CLIA Certification for Bioanalytical Laboratory
06 Feb 2024 //
BUSINESSWIRE
Celerion Receives a 2023 CRO Leadership Award in All Categories for the 8Y
10 May 2023 //
BUSINESSWIRE
Celerion Expands Molecular and Cellular Capabilities
11 Nov 2022 //
CONTRACTPHARMA
Celerion Expands Its Service Offering to Include GLP/GCP Compliant Molecular
10 Nov 2022 //
BUSINESSWIRE
H.I.G. Capital Completes Acquisition of Celerion
03 Nov 2022 //
BUSINESSWIRE
Celerion Invests in ADME Suite of Services
06 Apr 2022 //
CONTRACTPHARMA
Celerion Announces Investment in ADME Suite of Services
06 Apr 2022 //
PRNEWSWIRE
Celerion Expands Early Phase Clinical Pharmacology Units
09 Mar 2022 //
CONTRACTPHARMA
Celerion to Present at Upcoming Veeva Summit
09 Oct 2020 //
PRNEWSWIRE
Celerion Expands HRMS Metabolite Identification for Metabolism Offering
05 Jun 2020 //
BUSINESSWIRE
Celerion Expands Clinical Research to Nebraska Innovation Campus
10 Feb 2020 //
PRESS RELEASE